Sep 25, 2018
Technologies have been honed to overcome many of the challenges of administering peptide therapeutics orally, but obstacles remain before drug developers can fully realise the vast potential.
Proteins and peptides are the building blocks of life and have evolved to become a very promising basis for targeting a range of diseases.
Over the past 30 years, and especially the last 10 years, there has been a rapid growth in the development of therapeutic proteins, with a dramatic increase in the number of protein-based drugs on the market.
Original article by Dr Paul Shields
If you'd like to view the original article then follow the link below:
You can also download the original article pdf here:
For more information on Drug Discovery World, head to: